Association of Interleukin-32 and Interleukin-34 with Cardiovascular Disease and Short-Term Mortality in COVID-19

Background: Excess cardiovascular (CV) morbidity and mortality has been observed in patients with COVID-19. Both interleukin-32 (IL-32) and interleukin-34 (IL-34) have been hypothesized to contribute to CV involvement in COVID-19. Methods: This prospective, observational study of patients with labor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaufmann, Christoph C., Ahmed, Amro, Muthspiel, Marie, Rostocki, Isabella, Pogran, Edita, Zweiker, David, Burger, Achim Leo, Jäger, Bernhard, Aicher, Gabriele, Spiel, Alexander O., Vafai-Tabrizi, Florian, Gschwantler, Michael, Fasching, Peter, Wojta, Johann, Huber, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917403/
https://www.ncbi.nlm.nih.gov/pubmed/36769623
http://dx.doi.org/10.3390/jcm12030975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917403/
https://www.ncbi.nlm.nih.gov/pubmed/36769623
http://dx.doi.org/10.3390/jcm12030975

Ejemplares similares